001     14181
005     20250112183548.0
022 _ _ |2 (DE-600)1182884-5
|a 1354-3784
022 _ _ |a 1354-3784
|l 1744-7658
022 _ _ |a 1744-7658
024 7 _ |2 ZDBID
|a PERI:(DE-600)2030114-5
024 7 _ |2 ZDBPPN
|a ZDPPN:020990359
024 7 _ |2 EZBID
|a PERI:(DE-606)8539
024 7 _ |2 OCLC
|a OCLC:1368159265
024 7 _ |2 JCR
|a JCR:EXPERT OPIN INV DRUG
024 7 _ |2 ISI
|a WOS:EXPERT OPINION ON INVESTIGATIONAL DRUGS
024 7 _ |2 SCOPUS
|a SCOPUS:21351
024 7 _ |2 Medline
|a medline:9434197
035 _ _ |a PERI:(DE-600)2030114-5
040 _ _ |a 0355
|b ger
|c DE-101
|d JOIN²
|e JOIN² journal identification
041 _ _ |a eng
044 _ _ |c XA-GB
082 _ _ |2 22sdnb
|a 610
|q DE-600
082 7 4 |2 22sdnb
|a 610
|q DE-600
084 _ _ |2 fid
|a PHARM
|q DE-84
084 _ _ |2 ssgn
|a 15,3
210 0 _ |2 DE-600
|a Expert Opin Investig Drugs
210 0 _ |2 dnlm
|a Expert Opin Investig Drugs
210 0 _ |2 iso
|a Expert Opin Investig Drugs
242 2 0 |2 DE-600
|a Expert opinion on investigational drugs
|b EOID
|y en
242 2 0 |2 DE-600
|a Expert opinion on investigational drugs
|b EOID
245 _ _ |2 DE-600
|a Expert opinion on investigational drugs
|b EOID
|h print, online
246 3 _ |2 DE-600
|a Expert opinion on investigational drugs
246 3 _ |a Expert opinion on investigational drugs
246 3 _ |a EOID
260 _ _ |a Abingdon, Oxon
|b Routledge, Taylor & Francis
|c 1994-
260 _ 1 |0 Host:(DE-Juel1)46
|2 DE-Juel1
|a Taylor & Francis
264 2 1 |3 anfangs
|a London [u.a.]
|b Informa Healthcare
264 3 1 |a Abingdon, Oxon
|b Routledge, Taylor & Francis
|c 1994-
362 0 _ |2 DE-600
|a Nachgewiesen 3.1994 -
363 0 1 |2 DE-600
|8 1.1\x
|a 3
|i 1994
380 _ _ |2 marcgt
|a journal
500 _ _ |a Automatically generated record. (Updated: 2024-12-18)
650 _ 7 |0 ASJC:2736
|2 ASJC
|a Pharmacology (medical)
650 _ 7 |0 ASJC:3004
|2 ASJC
|a Pharmacology
776 0 8 |2 DE-600
|d London : Informa Healthcare, 1994-
|i Erscheint auch als
|n Druck-Ausgabe
|t Expert opinion on investigational drugs
|w (DE-600)1182884-5
|x 1354-3784
856 4 _ |d 0
|u https://ezb.ur.de/?2030114-5
|y EZB
856 4 _ |d 0
|u https://www.tandfonline.com/loi/ieid20
|y Verlag; 3.1994 - 18.2009 = Deutschlandweit zugänglich
880 1 _ |2 DE-600
|a Expert opinion on investigational drugs
|b EOID
909 C O |o oai:juser.fz-juelich.de:74187
|p authority:PERI
|p authority
909 C O |o oai:juser.fz-juelich.de:74187
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b EXPERT OPIN INV DRUG : 2022
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)1120
|2 StatID
|a DBCoverage
|b BIOSIS Reviews Reports And Meetings
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-18
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b EXPERT OPIN INV DRUG : 2022
|d 2024-12-18
980 _ _ |a PERI
980 _ _ |a AUTHORITY


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21